title: Tumor necrosis factor and isolated hepatic perfusion: from preclinical tumor models to clinical studies.
authors.affiliation: Department of Surgical Oncology, Erasmus Medical Center-Daniel den Hoed Cancer Center, Rotterdam, The Netherlands. devries(a)-hlkd.azr.ni
authors.forename: Mark R
authors.initials: MR
authors.lastname: de Vries
authors.forename: Timo L M
authors.initials: TL
authors.lastname: ten Hagen
authors.forename: Andreas W K S
authors.initials: AW
authors.lastname: Marinelli
authors.forename: Alexander M M
authors.initials: AM
authors.lastname: Eggermont
mesh_terms: D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D010478:Chemotherapy, Cancer, Regional Perfusion / Q000379:methods*; D002986:Clinical Trials as Topic; D004195:Disease Models, Animal; D004353:Drug Evaluation, Preclinical; D006801:Humans; D008099:Liver / Q000098:blood supply; D008113:Liver Neoplasms / Q000188:drug therapy* / Q000556:secondary; D008114:Liver Neoplasms, Experimental / Q000188:drug therapy* / Q000556:secondary; D014409:Tumor Necrosis Factor-alpha / Q000494:pharmacology / Q000627:therapeutic use*
chemical_list: D000970:Antineoplastic Agents; D014409:Tumor Necrosis Factor-alpha